Three-dimensional in vitro culture models in oncology research
Cancer is a multifactorial disease that is responsible for 10 million deaths per year. The intra-
and inter-heterogeneity of malignant tumors make it difficult to develop single targeted …
and inter-heterogeneity of malignant tumors make it difficult to develop single targeted …
Development of polymeric nanoparticles for blood–brain barrier transfer—strategies and challenges
Neurological disorders such as Alzheimer's disease, stroke, and brain cancers are difficult to
treat with current drugs as their delivery efficacy to the brain is severely hampered by the …
treat with current drugs as their delivery efficacy to the brain is severely hampered by the …
Limitations of animal studies for predicting toxicity in clinical trials: is it time to rethink our current approach?
GA Van Norman - JACC: Basic to Translational Science, 2019 - jacc.org
Animal testing is used in pharmaceutical and industrial research to predict human toxicity,
and yet analysis suggests that animal models are poor predictors of drug safety in humans …
and yet analysis suggests that animal models are poor predictors of drug safety in humans …
Recent progress in extrusion 3D bioprinting of hydrogel biomaterials for tissue regeneration: a comprehensive review with focus on advanced fabrication techniques
Over the last decade, 3D bioprinting has received immense attention from research
communities for develo** functional tissues. Thanks to the complexity of tissues, various …
communities for develo** functional tissues. Thanks to the complexity of tissues, various …
[HTML][HTML] The current state of animal models in research: A review
NB Robinson, K Krieger, FM Khan, W Huffman… - International Journal of …, 2019 - Elsevier
Animal models have provided invaluable information in the pursuit of medical knowledge
and alleviation of human suffering. The foundations of our basic understanding of disease …
and alleviation of human suffering. The foundations of our basic understanding of disease …
[HTML][HTML] Alzheimer's disease: treatment strategies and their limitations
Alzheimer's disease (AD) is the most frequent case of neurodegenerative disease and is
becoming a major public health problem all over the world. Many therapeutic strategies …
becoming a major public health problem all over the world. Many therapeutic strategies …
[HTML][HTML] Microfluidic organ-on-a-chip models of human intestine
Microfluidic organ-on-a-chip models of human intestine have been developed and used to
study intestinal physiology and pathophysiology. In this article, we review this field and …
study intestinal physiology and pathophysiology. In this article, we review this field and …
Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better?
LL Ma, YY Wang, ZH Yang, D Huang, H Weng… - Military Medical …, 2020 - Springer
Methodological quality (risk of bias) assessment is an important step before study initiation
usage. Therefore, accurately judging study type is the first priority, and the choosing proper …
usage. Therefore, accurately judging study type is the first priority, and the choosing proper …
The druggable genome and support for target identification and validation in drug development
Target identification (determining the correct drug targets for a disease) and target validation
(demonstrating an effect of target perturbation on disease biomarkers and disease end …
(demonstrating an effect of target perturbation on disease biomarkers and disease end …
The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta‐analysis, and clinical practice guideline: a systematic …
X Zeng, Y Zhang, JSW Kwong, C Zhang… - Journal of evidence …, 2015 - Wiley Online Library
Objective To systematically review the methodological assessment tools for pre‐clinical and
clinical studies, systematic review and meta‐analysis, and clinical practice guideline …
clinical studies, systematic review and meta‐analysis, and clinical practice guideline …